Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms

Fator do impacto: 1.211

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volumes:
Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v7.i3.890
456 pages

Dissemination of Case Studies on Ganotherapy

H. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh
S. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh
A. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh
K. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh

RESUMO

The treatment of various ailments through Ganotherapy has been initiated very recently in India and is now under experiment. However, the experiment has found some advances in the treatment of various ailments, which has been revealed through observations of different patients' ages ranging from 5 to 65 years. The time span of the ailments from which the patients suffered was 1.5 to 13 years. The purpose of the observation was to evaluate the effectiveness of the prescribed Ganoderma spp. capsules. The efforts were intended for promoting alternative medication for curing and maintaining health and at the same time creating social acceptance, adaptation, and affordability of this treatment among a greater segment of people.
During the study period, there were 20 different patients closely monitored after ingesting 500 mg capsules in various doses. All the cases were documented in a systematic way. The patients were suffering from low blood pressure (1), asthma (4), liver and stomach problem (1), obesity and health maintaining (1), prostate cancer (1), diabetes (1), paralysis (1), uterus tumor (1), gangrene (1), blood dysentery (1), respiratory and weakness problem (1), gastritis and gout (1), sinusitis and teeth problem (1), piles (1), rheumatic fever and brain disorder (1), kidney problem (1), and gynecological unwanted pains (1). According to our observations, it has been found that 80% of the patients were cured and are now leading a better quality of daily life.
It may be urged and stressed that a wider scope of clinical research work on Ganotherapy in the country is needed. International collaborative research and development activity is encouraged and welcomed on an urgent basis to continue clinical research.